Pacific Biosciences Of California (PACB) Capital Expenditures Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | 119.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.08% |
| Dec 31, 2025 | -46.75% |
| Sep 30, 2025 | 89.07% |
| Jun 30, 2025 | -62.81% |
| Mar 31, 2025 | -64.19% |
| Dec 31, 2024 | -20.11% |
| Sep 30, 2024 | -194.82% |
| Jun 30, 2024 | -34.79% |
| Mar 31, 2024 | 4.25% |
| Dec 31, 2023 | -58.73% |
| Sep 30, 2023 | -80.19% |
| Jun 30, 2023 | -43.57% |
| Mar 31, 2023 | 2.28% |
| Dec 31, 2022 | 72.55% |
| Jun 30, 2022 | 156.15% |
| Mar 31, 2022 | 807.23% |
| Dec 31, 2021 | 4,141.79% |
| Jun 30, 2021 | 391.85% |
| Mar 31, 2021 | 242.74% |
| Dec 31, 2020 | -52.48% |
| Sep 30, 2020 | -35.34% |
| Jun 30, 2020 | -47.96% |
| Mar 31, 2020 | -90.66% |
| Dec 31, 2019 | 143.10% |
| Sep 30, 2019 | 763.54% |
| Jun 30, 2019 | -54.79% |
| Mar 31, 2019 | 264.24% |
| Dec 31, 2018 | -94.53% |
| Sep 30, 2018 | -97.05% |
| Jun 30, 2018 | -60.67% |
| Mar 31, 2018 | -87.11% |
| Dec 31, 2017 | -60.02% |
| Sep 30, 2017 | 41.55% |
| Jun 30, 2017 | 23.23% |
| Mar 31, 2017 | 483.81% |
| Dec 31, 2016 | 201.94% |
| Sep 30, 2016 | 401.31% |
| Jun 30, 2016 | 192.98% |
| Mar 31, 2016 | -36.26% |
| Dec 31, 2015 | 84.07% |
| Sep 30, 2015 | 141.58% |
| Jun 30, 2015 | 105.38% |
| Mar 31, 2015 | 50.31% |
| Dec 31, 2014 | 367.65% |
| Sep 30, 2014 | -17.39% |
| Jun 30, 2014 | 66.07% |
| Mar 31, 2014 | 60.61% |
| Dec 31, 2013 | -76.82% |
| Sep 30, 2013 | -52.28% |
| Jun 30, 2013 | -44.77% |
| Mar 31, 2013 | 8.39% |
| Dec 31, 2012 | -69.40% |
| Sep 30, 2012 | -78.65% |
| Jun 30, 2012 | -87.61% |
| Mar 31, 2012 | -81.68% |
| Dec 31, 2011 | 17.01% |
| Sep 30, 2011 | 117.53% |